BioSpace News Archive

NeuroSense Therapeutics Ltd. today announced results from its multi-dose PK study (NCT05436678) of its lead drug candidate PrimeC for the treatment of amyotrophic lateral sclerosis (ALS).

Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) ( OTCQB:OTLC ), developer of treatments for rare and orphan indications, including Parkinson Disease, Pancreatic Cancer, and DIPG, today announced that the Company will be presenting at the upcoming SITC 37th Annual Meeting, held November 10-12, 2022, in Boston, MA.

Myriad Genetics, a leader in genetic testing and precision medicine, announced results from a nationwide survey it conducted on the attitudes, knowledge, and practices related to risk assessment, prevention, and screening for breast and ovarian cancer.

PolyPid Ltd. announced that it has received confirmation from the European Medicines Agency that D-PLEX100 is eligible for submission of a Marketing Authorization Application in the European Union under the Agency’s centralized procedure.

Abbott will announce its third-quarter 2022 financial results on Wednesday, Oct. 19, 2022, before the market opens.

Shanghai Henlius Biotech, Inc. (2696.HK) announced that ASTRUM-005, an international multi-centre study led by Professor Ying Cheng, has been published in The Journal of the American Medical Association (JAMA, impact factor of 157.3), one of the top four medical journals in the world.

Brand Institute is proud to announce its work with Heron Therapeutics in developing the brand name APONVIE™, which was approved by the FDA September 16, 2022.

Point Robotics MedTech Inc. (Point Robotics), a rising star in the field of orthopedic surgery, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its minimally invasive surgical robot, POINT™ Kinguide Robotic-Assisted Surgical System, in August.

An affiliate of funds advised by SK Capital Partners, LP (“SK Capital”) announced today that it has reached an agreement to acquire Apotex Pharmaceutical Holdings Inc.

CurvaFix, Inc ., a developer of medical devices to repair fractures in curved bones, today announced the addition of three new members to its Surgeon Advisory Board.